Colorectal Liver Metastases
📧 Sign up to get email alerts when something new happens for Colorectal Liver Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Patient Outcomes After Hepatic Artery Infusion Pump Placement
This clinical trial update reports patient outcomes after hepatic artery infusion pump placement in patients with colorectal cancer and colo…
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy [Phase 2]
Phase 2 clinical trial update investigating fruquintinib combined with tislelizumab and hepatic arterial infusion chemotherapy (HAIC) in adv…
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases [Phase 2]
Phase 2 clinical trial evaluating HAIC + tislelizumab + regorafenib for colorectal liver metastases is underway, with status currently unkno…
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases [Phase 2]
A Phase 2 clinical trial update investigating a quintuple treatment method for patients with colorectal liver metastases who cannot undergo …
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: Yttrium-90 Carbon Microspheres in Patients With Unresectable Colorectal Liver Metastases [Phase 1, Phase 2]
Clinical trial update for Yttrium-90 carbon microspheres in unresectable colorectal liver metastases (Phase 1/Phase 2).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Efficacy of Irreversible Electroporation (IRE) for Central Colorectal Liver Metastases [Phase 2]
Phase 2 clinical trial update evaluating the efficacy of irreversible electroporation (IRE) for central colorectal liver metastases.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases [Phase 2]
Phase 2 trial evaluating Cetuximab/FOLFIRI with or without Oxaliplatin, and FOLFOXIRI with or without Bevacizumab for neoadjuvant treatment …
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases
A clinical trial assessing whether pre-operative bevacizumab influences complications after surgical resection of colorectal liver metastase…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Health Related Quality of Life After Surgery and Oncological Treatment of Colorectal Liver Metastases
This trial update reports on health-related quality of life outcomes after surgery and oncological treatment for patients with colorectal li…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases.
Clinical trial update on a completed study comparing minor liver resections to major or extended hepatectomies for colorectal liver metastas…
-
CLINICAL_TRIALS trial_result · 2012-07-03Clinical Trial Update: Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors
Long-term oncologic outcomes and prognostic factors are reported for patients with colorectal liver metastases treated with minimally invasi…